AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
United Therapeutics (Nasdaq: UTHR) is a very smart, very innovative, and very profitable company.
First it treated an untreatable disease. Now it's disrupting the entire organ transplant industry.
In today's show, 7investing CEO Simon Erickson introduces United Therapeutics, describing why the company was created and its five commercially-approved drugs.
He also explains how its four synthetic organ programs could disrupt the entire organ transplant market.
See why United Therapeutics is a stock that should be on your radar. To join our free email list, visit 7investing.com/email.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode